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Abstract 
 Chronic alcohol consumption is a prevalent phenomenon linked to many 
behavioral constructs, including impulsivity and cognitive inflexibility, as well as 
neuropathology in brain regions central to these tasks such as the orbitofrontal and 
limbic cortices.  The detrimental effects of alcohol consumption are due to a confluence 
of factors that often occur in addition to alcoholism, importantly thiamine deficiency. This 
nutritional deficiency can manifest in the amnestic disorder Wernicke-Korsakoff 
Syndrome, most commonly seen in cases of alcoholism. In this study, we examined the 
effects of chronic alcohol exposure and thiamine deficiency in isolation, as well as in 
concert, to further our understanding of the independent effects of each treatment and 
how they interact. Furthermore, we included a group receiving chronic alcohol with 
thiamine supplementation to deduce whether the effects of long term alcohol exposure 
can be ameliorated with prophylactic treatment. Our results demonstrated that both 
chronic alcohol exposure and moderate thiamine deficiency induce an impulsive 
phenotype. Importantly, the increased impulsivity induced by thiamine deficiency was 
protracted as compared to that exhibited under conditions of chronic alcohol alone. 
Additionally, there may be decreased cellular activity in the posterior orbitofrontal cortex 
in chronically alcohol treated animals, as well as increased limbic cortical volume. 
However, differential pathology was observed in the chronic ethanol treated group 
presenting as increased limbic volume. This study has furthered our understanding of 
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the role of multiple factors in alcohol induced decision making deficits while illustrating 
the need to look at the interaction of chronic alcohol exposure induced mild thiamine 
deficiency. It also provides justification to investigate potential prophylactic treatments for 
alcoholics or those in treatment to prevent further neurological insult. 
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Introduction 
Alcohol consumption is ubiquitous across cultures. The lifetime prevalence of alcohol 
use disorders in males is 8.4%, and 4.2% of females according to the Substance Abuse 
and Mental Health Services Administration; additionally, 70.1% of the population 
reported using alcohol within the past year (SAMHSA, 2015). It has been established 
that chronic alcohol consumption can lead to brain damage.  
The detrimental effects of chronic alcohol exposure are due to a confluence of 
factors; not only does alcohol exposure alone induce cellular death and damage to 
neural tissue (Goodlett and Horn, 2001), but there are also common comorbid factors 
that cloud our ability to ascertain the effects of alcohol consumption in isolation.  Chronic 
compulsive alcohol consumption without a comorbid condition must be studied to 
increase our understanding of alcohol’s damaging effects because alcoholism is often 
‘complicated’ by the existence of other conditions such as liver disease, polydrug use, 
history of head trauma, or nutritional deficiency (Pitel, Zahr, Jackson, Sassoon, 
Rosenbloom, Pfefferbaum, and Sullivan, 2011; Sullivan and Pfefferbaum, 2005). It is 
important to understand the effects of chronic alcohol exposure in addition to each of 
these factors in isolation as well as the consequences of these common comorbidities in 
and of themselves.  
Chronic alcohol consumption alone has also been demonstrated in human 
studies and animal models to elicit neuropathology due to a confluence of molecular 
factors. Importantly, the most vulnerable regions include the orbitofrontal and cingulate 
cortices, with volume loss again being an expression of pathology (for review see 
Sullivan and Pfefferbaum, 2005; Volkow and Fowler, 2000; Ridderinkhof, Vlut, 
Bramlage, Spaan, Elton, Snel, and Band, 2002). Alcohol exposure can lead to apoptosis 
or necrosis (cell death), interfere with cellular function and alter cellular division rates, 
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depending on the type of cell and its developmental stage (for review see Goodlett and 
Horn, 2001; Bredensen, 1996 a, b). As will be discussed below, thiamine deficiency may 
also play a role in these processes. 
  As these studies have demonstrated, chronic alcohol consumption can be highly 
detrimental to the integrity of the brain. Importantly, comorbid conditions can exacerbate 
these effects, particularly nutritional deficiency. In the following section the effects of 
thiamine deficiency, which can be induced by high levels of alcohol consumption, will be 
explored.  
 
Thiamine Deficiency in Alcoholism 
The confluence of nutritional deficiency in alcoholism is of particular interest, 
specifically in the case of thiamine deficiency, as this can result in Wernicke-Korsakoff 
Syndrome (WKS). WKS is a retrograde and anterograde diencephalic amnesic disorder 
most often seen in alcoholics, but also found in those with bulimia, gastrointestinal 
distress, starvation, long term IV usage, dialysis and AIDS (for review Mair, 1994; 
Kopelman, Thomson, Guerrini, and Marshall, 2009). Chronic alcoholics are prone to 
nutritional deficiency because they derive up to 41% of their calories from alcohol 
(Gruchow, Sobocinski, Barboriak, and Scheller, 1985). To further exacerbate this 
situation, chronic alcohol consumption also decreases absorption or utilization of 
nutrients (Galvin, Brathens, Ivashynka, Hillbom, Tanasescu, Leone, 2010) which may 
result in, or compound, the effects of nutritional deficiency.  
It is estimated that up to 80% of alcoholics are thiamine (vitamin B1) deficient due to 
poor nutrition (Galvin et al., 2010), however, approximately 75% of cases of thiamine 
deficiency are undiagnosed in alcoholics (for review see Zahr, Kaufman, and Harper, 
2011) and around 13% of alcoholics have thiamine deficiency induced neuropathology 
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(for review see Harper, Giles, and Finlay-Jones, 1986). There is also graded damage 
between these groups; milder brain and behavioral dysfunction is seen in uncomplicated 
alcoholics relative to complicated alcoholics with thiamine deficiency. (Pitel, et al., 2011; 
Sullivan, and Pfefferbaum, 2005). Therefore, it is clear why WKS is seen in cases of 
alcoholism. 
Thiamine deficiency can induce excitotoxic lesions to the thalamus (anterior and 
midline nuclei) and mammillary bodies which are a hallmark feature of the 
neuropathology seen in WKS (de Wardener and Lennox, 1947). Thalamic lesions are 
necessary to induce the amnestic disorder, however hippocampal damage is sometimes 
observed as well (for review see Kopelman, Thomson, Guerrini, and Marshall, 2009; 
Sullivan and Pfefferbaum, 2005). Additionally, frontal lobe atrophy, and white matter 
pathology are often detected. Particularly relevant to this study is the fact that the most 
vulnerable frontal regions include the orbitofrontal and cingulate cortices, which often 
present with decreased overall volume, reduced neuronal density, and decreased 
metabolism and blood flow (for review see Beaunieux, Eustache and Pitel, 2014; 
Sullivan, and Pfefferbaum, 2005). In addition to amnesia, WKS patients also present 
with impaired problem solving skills, poor content and contextual memory, deficits in 
spatial learning and memory, ataxia, oculomotor disturbances, and global confusion (for 
review see Savage, 2014; Savage, Hall, and Resende, 2012; Vetreno, Klintsova, and 
Savage, 2011; Roland, Mark, Vetreno, and Savage, 2008; Vetreno, Hall and Savage, 
2011; van Oort, and Kessels, 2009; Pitel, et al., 2011). 
 A contributing factor in chronic alcohol induced cell death may be due to 
alterations in gastric motility, and nutritional absorption caused by alcohol consumption 
(for review see Martin, Singleton, and Hiller-Sturmhofel, 2003; for review see Hoyumpa, 
1980). Specifically, the B vitamin, thiamine has been implicated in cellular death when 
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depleted as will be discussed in the following paragraphs (for review see Butterworth, 
2003).  
As reviewed by Martin et al. (2003), adult Homo sapiens require >0.33 mg of 
dietary thiamine per 1,000 calories consumed (0.66 mg per day given a 2,000 calorie 
diet) (Hoympa, 1980; Martin et al. 2003). However, in alcoholics, oral absorption of 
thiamine is minute to non-existent (Agabio, 2005; Thomson, 2000). Deficits in this 
vitamin disrupt a variety of metabolic pathways and the synthesis of numerous 
neurotransmitters and proteins.  
 Three enzyme systems are dependent on thiamine: transketolase, pyruvate 
dehydrogenase, and alpha-ketoglutarate. Transketolase is involved in the pentose 
phosphate pathway, which plays a role in myelination maintenance. Pyruvate 
dehydrogenase plays a role in energy production via the breakdown of pyruvate to the 
coenzyme Acetyl CoA, an enzyme also involved in the production of the 
neurotransmitter acetylcholine. Finally, alpha-ketoglutarate, a glutaric acid is involved in 
the formation of the neurotransmitters acetylcholine, GABA, and Glutamate (for review 
see Martin et al, 2003; Cook, Hallwood, and Thomson, 1998; Thomson and Pratt, 1992; 
Thomson, Jeyasingham, Pratt, and Shaw, 1986) as well as aspartate, another excitatory 
neurotransmitter (Martin et al, 2003). Thiamine is, therefore, central to the preservation 
of the myelin sheath, cellular energy reserves, and neurotransmitter synthesis. Based on 
these findings one can see how thiamine deficiency can lead to neuronal dysregulation 
on several fronts.  
 Adding fuel to the fire is the fact that thiamine deficiency also induces a selective 
downregulation of the glutamate transporters located at the astrocyte/synapse junction 
on the astrocytic cell in some brain regions (for review see Butterworth, 2003; Hazell, 
Rao, Danbolt, Pow, and Butterworth, 2001; Sheldon, and Robinson, 2007) exacerbating 
5 
 
the potential for both alcohol and thiamine deficiency induced cellular death. As 
discussed by Sheldon and Robinson (2007), extracellular metabolism of glutamate does 
not seem to occur once it is released. As such, it must be removed from the synaptic 
space by transporters, in this case by glutamate transporters (GLUTS) including GLT-1 
and GLAST.  These transporters are found on astrocytic processes proximal to the 
synaptic terminal where they are in a prime position for glutamate uptake and storage 
(for review see Sheldon and Robinson, 2007; Hazell et al., 2001). This down regulation 
of GLUTs leads to an increase in extracellular glutamate (for review see Butterworth, 
2003; Hazell et al., 2001). Due to the excitatory nature of glutamate, extracellular levels 
need to be regulated to prevent excitotoxicity induced cell death. These observations 
further implicate thiamine deficiency as a factor in the cell death induced by chronic 
alcohol exposure.  
 
Alcohol Addiction, Thiamine Deficiency, and Impulsivity 
 The propensity to consume excessive amounts of alcohol in addicted individuals, 
which may contribute to thiamine deficiency, also has a genetic component that should 
be considered. There is evidence that differential genetic backgrounds can alter 
susceptibility to the thiamine deficiency inducing effects of chronic alcohol consumption. 
Based on work by multiple researchers (for review see Martin et al., 2003; Tallaksen, 
Bohmer, and Bell, 1992; Hoyumpa, 1980; and Morgan, 1982) it appears that as high as 
80% of alcoholics may experience thiamine deficiency. However, as discussed by 
Harper et al., (1988), only ~13% of this population develop WKS. This indicates that 
there may be a subset of the population with a higher sensitivity to thiamine deficiency 
that may be more vulnerable to alcohol induced thiamine deficiency related brain 
damage (Harper, Gold, Rodriguez, and Perdices, 1989). Work investigating this point 
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has returned mixed results. For example, Mukherjee and colleagues (1987) observed 
that both alcoholic men and their alcohol naive sons had lower levels of thiamine 
diphosphate (metabolically active thiamine) than controls (Mukherjee, Svoronos, 
Ghazanfari et al., 1987). However, another study found no differences in thiamine 
diphosphate, indicating that there was not a difference in the transketolase enzyme 
necessary to add the diphosphate bonds to thiamine and render it active (Nixon, 
Kaczmarek, Tate, Kerr and Price, 1984). Because some work has demonstrated that 
moderate thiamine deficiency increased white matter pathology in a genetic model with 
alcohol exposure (He, Sullivan, Stankovic, Harper, and Pefferbaum, 2007), this opens 
an avenue for further investigation applying a thiamine deficient protocol to genetic 
models of addiction. Furthermore, the addiction phenotype includes pervasive executive 
function deficits, which may be exacerbated by thiamine deficiency and alcohol 
exposure, including impulse control deficits and perseverative behavior.  
Persistent, compulsive drug use without regard to consequences is a hallmark 
feature of addiction (for review see Hyman, Malenka and Nestler, 2006; for review see 
Crews and Boettiger, 2009; Hser, Hoffman, Grella, and Anglin, 2001; McLellan, Lewis, 
O’Brien, and Kleber, 2000). Although some regular users are able to abstain on their 
own, for many addiction is a chronic problem (Hyman, Malenka and Nestler, 2006). This 
compulsive behavior is related to deficits in reversal learning (Jentsch, Olausson, De La 
Garza and Taylor, 2002), perseverative behavior (related to reversal learning) (Hyman, 
2005), and impulsivity (for review see Jentsch and Taylor, 1999; Oberlin and Grahame, 
2009; Crews and Boettiger, 2009) and has long been associated with addiction as 
demonstrated by these animal models of drug exposure and genetic susceptibility as 
well as human studies examining decision making in similar tasks.  
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Executive Function Deficits: Impulsivity and Reversal Learning 
Impulsivity is a maladaptive inability to delay receipt of reward resulting in a net 
loss of reward (e.g. food, money) for the organism (Ainslie, 1975). Delay discounting 
paradigms are a highly translational behavioral assessment of impulsive choice behavior 
(referred to as impulsivity or impulsive choice here) contingent on the fact that the 
preference for a large immediate reward over a small one is conserved between species 
(Mazur, 1987; Oberlin and Grahame, 2009; Odum, 2011), and that as the wait to receive 
the reward increases over time the perceived value of said reward subjectively 
diminishes (Bechara, Dolan, and Hindes, 2002; Odum, 2011; Oberlin and Grahame, 
2009; Mars and Robbins, 2007; Mazur, 1987), hence “Delay Discounting”.  
Delay discounting can manifest as a maladaptive behavior leading to an inability 
of the organism to optimize the results of goal directed behavior due to an inordinate 
preference for small immediate gain regardless of the potential for overall long term gain 
and greater overall rewards accrued (Ainslie, 1975). Because immediate rewards are 
excessively valued during decision making, there is a tendency in some individuals to 
quickly change their preferences and decision making styles to favor an immediate short 
term reward over a deferred, but greater, reward (Mazur, 1987). 
In populations with a genetic predisposition towards addiction, drug naive 
impulsivity can be predictive of future drug consumption (Oberlin and Grahame, 2009; 
Beckwith and Czachowski, 2014). However, drug exposure has also been demonstrated 
to correlate with impulsivity. Beckwith and Czachowski (2014) demonstrated that high 
‘alcohol seeking’, but not ‘consumption’, positively correlates with increased delay 
discounting. This study used high alcohol drinking (HAD2) and alcohol-preferring (P) 
rats, both genetic models of alcoholism. Interestingly, only the ‘high seeking’ P rats 
demonstrated greater delay discounting than control Long-Evans rats, indicating that 
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there is a link between drug seeking and impulsivity that is independent of consumption 
(Beckwith and Czachowski, 2014). Furthermore, P rats have also been shown to have 
increased choice impulsivity (Perkel, Bentzley, Andrzejewski, and Martinetti, 2015 
(alcohol naïve); Linsenbardt, Smoker, Janetsian-Fritz, and Lapish, 2016 (vs parent 
strain)). Other rodent models selected for alcohol drinking have also exhibited 
differences in impulsivity subtypes. For example, the high drinking STDRH12 mouse has 
increased motor, but not choice, impulsivity (Wilhelm, Reeves, Philips, and Mitchell, 
2007). These studies indicate that, although impulsivity plays a role in addiction, it is not 
the only factor involved in the presentation of an addictive phenotype and that certain 
types of impulsivity and drug ‘seeking’ or ‘consumption’ may have separable roles.  
In human males with alcohol use disorders increased choice impulsivity is also 
observed. Additionally, these subjects exhibited hyperactivity in brain regions related to 
cognitive control and prospection; the dorsolateral prefrontal cortex and posterior parietal 
cortex, respectively (Amlung, Sweet, Acker, Brown, and MacKillop, 2014). A study 
examining females with alcoholism also demonstrated that there is increased choice 
impulsivity as well as increased activity in multiple brain regions related to cognitive 
control including the insula/orbitofrontal cortex (Claus, Kiehl, and Hutchison, 2011). This 
finding is in line with studies demonstrating the roles of the medial and lateral 
orbitofrontal cortex, anterior cingulate, and anterolateral prefrontal cortex in reward 
dependent decision making (for review see Rushworth, Noonan, Boorman, Walton, and 
Behrens, 2011, for OFC specific reviews see Wallis, 2007 and 2012). Another study, 
examining women, found increased impulsivity in heavy drinkers as well as decreased 
sensitivity to the aversive effects of alcohol consumption, which may increase abuse 
potential (Reed, Levin, and Evans, 2012). Increased impulsivity is also seen in 
numerous other addictive phenotypes ranging from nicotine use (Baker and Bickel, 
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2003) to compulsive gambling (MacKillop, Anderson, Castelda, Mattson, and Donovick, 
2006; MacKillop, Amlung, Few, Ray, Sweet, and Munaffo, 2011).  
Additionally, alcohol exposure during development and adolescence may 
increase impulsive choice behavior (Banuelos, Gilbert, Montgomery, Fincher, Wang, 
Frye, Setlow, and Bizon, 2012) as well as relate to other associated behaviors such as 
adolescent anxiety (Mejia-Toiber, Boutros, Markou, and Semanova, 2014; (Stein, 
Renda, Barker, Liston, Shahan, and Madden, 2015) and risk taking (Roman, Stewart, 
Bertholomey, Jensen, Colombo, Hyytia, Badia-Elder, Grahame, Li and Lumeng, 2012). 
Other decision making deficits also appear to contribute to this behavioral phenotype. 
Cognitive flexibility is also an executive function metric closely related to impulsivity and 
governed by many of the same brain regions, as will be discussed below. Deficits in 
cognitive flexibility, measured by reversal learning tasks, are also seen in models of 
addiction and alcohol exposure.  
Reversal learning tasks are another way to assess OFC function and evaluate 
potential decision making deficits. Successful reversal learning requires reflection on 
past stimulus-reward associations and the adaptation of behavior to accommodate 
changing reward contingencies, which are considered an essential element of emotional 
and social behavior.  Reversal learning tasks examine both affective (emotion based) 
decision making and learning, in addition to assessing the ability to alter behavioral 
response when presented with changes in stimulus-reward associations (Franken, van 
Strien, Nijs and Muris, 2008). Reversal learning is also used to assess both compulsive 
and impulsive behavior, and OFC function in addiction (for review see Izquierdo and 
Jentsch, 2012). Additionally, in the case of delay discounting tasks, reversal learning 
may also be an inherent part of the task as the perception of the ‘preferred lever’ is 
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altered with increasing delay, which may confound the discrimination between reversal 
learning deficits and a propensity toward impulsive choice behavior. 
 
Brain Regions Governing Impulsivity and Cognitive Flexibility 
Impulsivity and cognitive flexibility are both governed largely by the orbitofrontal 
cortex as has been demonstrated by numerous studies. For example, lesions to the 
orbitofrontal cortex result in the inability of animals to modify their responding following 
alterations in reward contingencies (Chudasama, Passetti, Rhodes, Lopian, Desai, and 
Robbins, 2003; for review see Clark, Cools, and Robbins, 2004; Boulougouris, Dalley, 
and Robbins, 2007) because this area encodes for violations of reward expectation, with 
reversal responding supported by the lateral OFC specifically (Ghahremani, Monterosso, 
Jentch, Bilder, and Poldrack, 2010). Damage to the OFC has been shown to lead to 
impulsivity, behavioral inflexibility, and emotional disorder (Roberts and Wallis, 2000). 
Loss of inhibitory control of affective responding has been implicated in impaired 
reversal learning. Deficits may also present themselves as a failure to avoid short term 
reward that leads to long term negative consequences (choice impulsivity) (Clark, Cools, 
and Robbins, 2004). There is substantial evidence suggesting that there is orbitofrontal 
dysfunction in addicts, which may contribute to compulsive behavior (Everitt, Belin, 
Economidou, Pelloux, Dalley, and Robbins, 2008). In cases of frontotemporal dementia 
with OFC pathology, compulsive behaviors have been reported including hyperphagia, 
gambling, and substance abuse. OFC damage in humans, as well as non-human 
primates and rodents, has led to addictive behavior (Crews and Boettiger, 2009). 
Additionally, there is evidence from human neuroimaging studies, as well as animal 
studies, examining cellular activity that corroborates these findings.   
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Neuroimaging studies performed on healthy subjects have shown that the 
prefrontal cortex is activated during reversal learning tasks, and that deficits in reversal 
learning are correlated with damage to the OFC (Franken et al, 2008). The role of these 
areas in reversal learning is further supported by studies recording the activity of single 
cells in the orbitofrontal cortex, which have confirmed that the firing of neurons in this 
region changes in response to alterations in reward contingencies. Importantly, neurons 
in the macaque OFC have been shown to reverse from firing at the presentation of 
previously rewarded stimulus to a currently rewarded stimulus (for review see Clark, 
Cools, and Robbins, 2004; Rolls, Critchley, Mason, and Wakeman, 1996; Thorpe, Rolls, 
and Maddison, 1983) implicating them in cognitive flexibility when reward contingencies 
change. 
Shoenbaum and colleagues have demonstrated that the orbitofrontal cortex 
plays a particularly pivotal role in the assessment of expected and received outcomes 
(for review see Shoenbaum, Roesch, and Stalnaker, 2006), important in decision making 
tasks central to this study (delay discounting and reversal learning). Human 
neuroimaging studies have demonstrated that there are changes in blood flow in the 
OFC both while anticipating outcomes and when the expected outcome is altered or not 
attained (Gottfried, O’Doherty, and Dolan, 2003; Gottfried, O’Doherty, and Dolan 2002; 
O’Doherty, Deichman, Critchley, and Dolan, 2002; Nobre, Coull, Frith, and Mesulam, 
1999). This change appears to be associated with reward value and is observed when 
this information is being processed in decision making (Arana, Parkinson, Hinton, 
Holland, Owen, and Roberts, 2003). Animal studies have demonstrated that the neurons 
in the OFC fire differentially depending on reward salience including expected size, time 
to attainment, and possible consequences of incorrect behavior (Schoenbaum, Stelow, 
Saddoris, and Gallagher, 2003; Schoenbaum, Chiba, and Gallagher, 1998; Tremblay 
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and Schultz, 1999; Roesch and Olson, 2004; Roesch and Olson, 2005) making them 
critical in delay discounting tasks which require the assessment of reward size and time 
to attainment. If an expected reward is not obtained, or is devalued (ex: by time), there is 
a decrease in this responding (Tremblay, and Schultz, 1999). Thus, outcome 
expectancies encoded by the OFC are critical to adaptive learning (Saddoris, Gallagher, 
and Schoenbaum, 2005). Additionally, there is evidence that the maladaptive decision 
making processes associated with drug addiction may result from drug induced changes 
to this region (London, Ernst, Grant, Bonson, and Weinstein, 2000; Rogers, Everitt, 
Baldacchino, Blackshaw, Swainson, Wynne, Baker, Hunter, Carthy, Booker, London, 
Deakin, Sahakian, and Robbins, 1999; Porrino, and Lyons, 2000; for review see Dom, 
Sabbe, Hulstiin, and Van Den Brink, 2005). This possibility indicates that an underlying 
deficit in this behavior could be exacerbated by drug and alcohol exposure, as well as 
thiamine deficiency. 
The limbic cortex (infralimbic and prelimbic regions encompassing the medial 
prefrontal cortex) is implicated in response inhibition, which also relates to an impulsive 
phenotype as the organism’s inability to suppress the impulse to respond although it has 
been learned that no reward can be elicited (Chudasama, Passetti, Rhodes, Lopain, 
Desai, and Robbins, 2003). Studies have demonstrated that the limbic region is not 
involved in successful reversal learning, however. These experiments have shown that 
there is functional selectivity in this type of task. While the OFC and limbic cortices both 
play a role in impulsivity, the OFC alone was implicated by these lesion studies 
(Boulougouris, Dalley, Robbins, 2007).  
Recent work in this lab, using an animal model, has demonstrated that thiamine 
deficiency in conjunction with chronic ethanol exposure impaired cognitive flexibility. This 
study used spontaneous alternation and attentional set shifting to assess this aspect of 
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executive function. Additionally, these results supported the potential that sub-clinical 
thiamine deficiency may exacerbate the cognitive deficits induced by chronic alcohol 
consumption (Vedder, Hall, Jabrouin, and Savage, 2015). Here, we further this line of 
inquiry into executive function assessments and how this behavior can be altered by a 
variety of treatments. We investigated the effects of chronic ethanol consumption, 
thiamine deficiency, thiamine supplementation, and the combination of those variables 
on behavioral tasks that are highly dependent on the frontal cortex. We assessed 
impulsivity using an operant delay discounting task and incorporated a reversal of 
reward contingencies to examine differences in impulsivity and cognitive flexibility 
induced by these treatments. Following these tasks, we examined the neuropathology 
induced by thiamine deficiency; thalamic cell loss using NeuN to stain neuronal cell 
bodies. The immediate early gene Arc was then used to examine neuronal activity in the 
OFC and infralimbic/prelimbic cortices. Additionally, Cavalieri volumetric analysis was 
used in conjunction with NeuN staining to assess possible changes in the volume of the 
OFC and limbic cortices. The results of this investigation allow us to further tease apart 
the roles of the OFC and limbic cortices in impulsivity and cognitive flexibility as well as 
the effects of alcohol exposure, thiamine deficiency, and the comorbid treatments on 
these brain regions and the associated behavioral constructs. 
 
Methods 
Subjects 
 This experiment used 56 adult male Sprague-Dawley rats (Envigo, Indianapolis, 
IN, USA) that where 3-4 months at the start of treatment. Rats were randomly assigned 
to one of 6 treatment groups (see Vedder et al, 2015); Pair Fed (PF) control group; 
Chronic Ethanol Treatment (CET); Chronic Ethanol Treatment with IP Thiamine 
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supplementation (CET-Th); Chronic Ethanol Treatment in conjunction with IP injections 
of Pyrithiamine hydrobromide (CET-PTD); PTD-EAS (Pyrithiamine induced Thiamine 
Deficiency-Early Acute Stage; and PTD-MAS (Pyrithiamine induced Thiamine 
Deficiency-Middle Acute Stage). The initial N consisted of 8-9 per group, though some 
subjects were lost due to failure to thrive post-treatment or advanced age resulting in a 
final N of 48. Additionally, tissue damaged during processing resulted in the loss of some 
subjects and varied group sizes in immunohistological assays. All experiments were 
conducted according to the Committee for the Update of the Guide for the Care and Use 
of Laboratory Animals (2011). All experimental protocols were approved by the 
Institutional Animal Care and Use Committee at the State University of New York at 
Binghamton. 
Treatments  
Chronic Ethanol Treatment: Ethanol treated groups (CET, CET-Th, CET-PTD) 
were exposed to increasing concentrations of ethanol using a ‘Fading On’ procedure 
during which subjects receive 6%, 9%, 12% and subsequently 20% ethanol in tap water 
in five day increments. Following six months of 20% ethanol in tap water, animals were 
titrated off using the reverse of this procedure, termed ‘Fading Off’. During ethanol 
exposure, tail blood samples were taken and analyzed for blood ethanol concentration 
(BEC) via ANALOX at month 1, 2/3, 4, and 6. Consumption was assessed twice a week 
(by taking bottle weights) for these animals. PF animals also had their fluid consumption 
(tap water) monitored and had blood samples taken at the above-mentioned times. CET-
Th subjects received IP injections of thiamine hydrochloride (0.4 mg/kg IP) three times a 
week, in addition to chronic ethanol exposure, and had BECs taken at the same time as 
samples were collected from other ethanol groups (Figure 1). 
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 Pyrithiamine-induced Thiamine Deficiency (TD): Thiamine deficient groups (CET-
PTD, PTD-EAS, and PTD-MAS) received ad libitum thiamine deficient chow (Envigo 
Diets, IN, USA) and received daily injections of pyrithiamine hydrobromide, which 
prevents thiamine from becoming metabolically active, (0.25 mg/kg IP; Sigma-Aldrich, 
St. Louis, MO) beginning 1 month into ethanol exposure in CET treated groups.  About 
12-13 days after the start of PTD treatment neurological symptoms (anorexia, ataxia, 
loss of righting reflexes, and ultimately opisthotonus (spasm) were recorded hourly. Rats 
were treated to different severity levels of TD, consisting of: (i) an early acute stage 
(PTD-EAS and CET-PTD) in which rats were reversed with a bolus of 0.5 cc of thiamine 
hydrochloride (100 mg/ml, IP; Sigma-Aldrich) within 1 hour after the appearance of 
opisthotonus and (ii) a moderate acute stage (PTD-MAS) when rats were reversed after 
4.25 hours following seizure.  
Combined Treatments of CET and PTD: To assess the potential synergistic 
interactions between CET and TD, a subset of rats (CET-PTD) were exposed to the 
PTD-EAS stage while they were exposed to 20% v/v ethanol. Following reversal, all PTD 
rats were returned to normal rat chow and given a second thiamine reversal injection 24 
hours later.  
Pair fed (PF) control subjects also received thiamine deficient chow during this 
symptom onset dependent 14-17 day period, however, they also received daily 
injections of thiamine hydrochloride (0.4 mg/kg IP; Sigma-Aldrich, St. Louis, MO). To 
mimic the anorexic effects of thiamine deficiency, PF animals were food deprived during 
the period of weight loss prior to the onset of symptoms experienced by thiamine 
deficient groups to match weight loss experienced by these subjects. All subjects were 
given three weeks to recover and regain their free feeding weights prior to behavioral 
testing. This paradigm has been previously described in work from this lab (Vetreno, 
Klintsova, and Savage, 2011; Pitkin and Savage, 2000) and has been demonstrated to 
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produce no differences, relative to untreated controls, in progenitor cell proliferation, 
neurogenesis, (Vetreno, Klintsova, and Savage, 2011) or thiamine dependent enzymes 
(Butterworth and Heroux, 1989).  
Behavioral Assessments 
Prior to behavioral testing all treatment groups underwent 7 days of food 
restriction to achieve weights of 85 +/-5% free feeding weight, at which point delay 
discounting testing commenced. Additionally, all animals were handled for five minutes a 
day for 5 days prior to the initiation of testing and acclimated to BioServe (Flemington, 
NJ, USA) Dustless Precision reward pellets (.5 g, unflavored) in their home cages during 
this time. 
Operant Delay Discounting and Reversal Learning 
Operant boxes consisted of 12 large rodent testing chambers (Med Associates 
Inc, St. Albans, VT, USA) measuring 55.9 cm X 55.9.cm X 35.6 cm. Each operant box 
was contained within a sound and light attenuated chamber with a ventilation fan. Head 
entry detectors were centered on the 35.6 cm side connected to external pellet 
dispensers which deposited pellets in the head entry trough. Levers were located 3 cm 
away from the head entry detector on either side at approximately 11 cm high. A single 
house light was centered on the opposite wall 27 cm high.  
 
Behavioral Testing 
Initial and Reversal Delay Discounting  
Following home cage exposure to reward pellets, subjects were trained on 
programs of ascending difficulty; beginning with habituation, autoshaping, Fixed Ratio-1 
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(FR1), Fixed Ratio-2 (FR2). Habituation consisted of 90-minute session during which the 
rats were exposed to the operant boxes. The following day autoshaping was conducted; 
this consisted of a 60 min session during which levers were randomly presented 
individually and presses were rewarded until 60 trials were completed. Failure to lever 
press during this 60 min task resulted in extended autoshape training done overnight. 
The side that received the majority of presses during this procedure was deemed the 
preferred side and designated the ‘delayed reward lever’ in later trials. 
After completion of this task, rats were presented with a FR1 program during 
which the house light would come on signaling the start of a trial.  They then had to 
place their head into the nose poke, breaking a photoreceptor beam to start the trial. At 
that time the levers extended and the rat would have to press once to receive a 1 pellet 
reward. The levers retracted and the house light went out for a 100 sec inter-trial interval 
(ITI). In order to move on to the next phase, the rat had to have a side preference of less 
than 75%. 
If a rat had a side preference greater than 75%, remedial training was done 
consisting of a FR1 task in which only one lever at a time was pseudo-randomly 
presented. Completion of this task with choice behavior below the 75% ceiling moved 
the animal on to FR1 where their performance was evaluated again to ascertain that 
they would not exhibit a substantial side preference. 
 The FR2 program differed only in that the rat now had to make two lever 
responses to receive the reward. The previously described 75% ceiling on side 
preference remained in place and if the rat failed to perform below this criterion it was 
again given remedial training consisting of an amended program that presented the 
animals with a pseudo-randomized combination of 30 forced trails that presented the 
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non-preferred lever and 30 random trials. Following this task, the rat was again 
presented with the FR2 program and given another opportunity to reach criterion.  
These pretraining programs culminated in a 0 Delay version of the Delay 
Discounting program, during which reward discrimination was assessed. Once it was 
established that each subject could discriminate reward magnitude, determined to be a 
preference for a large, immediate (4 pellet) versus small, immediate (1 pellet) reward 
75% of the time, they were exposed to the delay discounting program.  
The delay discounting task was adapted from Mar and Robbins (2007) and 
presented each subject with the opportunity to receive a small or large reward by 
pressing one of two levers with predetermined designations. This was an ascending 
delay paradigm beginning with a block at a 0 second delay and progressing to 10, 20, 
40, and 60 seconds. Each block of delays consisted of 10 delay trials daily. The first 
session began with 4 forced choice trials (2 forced trials occurred prior to subsequent 
delay blocks) where levers were presented individually, which ensured that the subject 
was exposed to both reward magnitudes.  
Each delay block was initiated by the presentation of the house light, which 
signaled the opportunity for the rat to nose poke, breaking a photoreceptor beam and 
initiating the trial (failure to nose poke was coded as a ‘nose poke omission’). At this 
point both levers would extend simultaneously, affording the animal the ability to press 
either lever to obtain a reward. The rats had 10 seconds to respond by lever press, if 
they failed to respond this would be counted as a “lever press omission”. Following a 6-s 
consumption interim, the house light would go off for a 100 second inter-trial interval 
prior to the initiation of the next trial. Once the subject reached behavioral stability, 
deemed no differences in choice behavior greater than 25% for each consecutive delay 
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for two three-session blocks, they progressed to the next phase of behavioral testing 
(Reversal Learning). 
Latency to nose poke and press levers were also recorded for later assessment 
of individual/group differences in motivation. At the point of behavioral stability, 
determined by no choice variation greater than 25% over the course of 6 consecutive 
testing days when comparing across discrete delay intervals, the reversal phase 
commenced the following day with delay times remaining consistent. The number of 
sessions required to reach behavioral stability was recorded. 
Importantly, which lever was pressed at each delay point was recorded allowing 
for the assessment of changes in lever preference as a function of delay; determining 
the subjective value of the reward for each rat as the time to receive said reward 
increased incrementally across trials. This is the critical component of this task which 
allows for interpretations regarding the impulsive choice behavior of each treatment 
group. 
Reversal Learning 
Reversal learning was evaluated using the same program as the delay 
discounting task, however reward contingencies were changed such that the lever 
previously associated with receiving the large reward was now providing the smaller 
reward. All other contingencies being equal, this forced the subjects to re-evaluate the 
reward parameters of the task and alter behavioral responses accordingly. This 
assessment continued until the subjects again reached behavioral stability, defined as 
no choice variation greater than 25% over the course of 6 consecutive testing days when 
comparing across discrete delay intervals. After the subject met this criterion, the 
reversal phase was initiated. The number of sessions required to reach behavioral 
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stability was recorded. or a 40 day testing ceiling, resulting in a post-reversal delay 
discounting curve. 
Nose poke and lever omissions were also recorded for later assessment of 
individual/group differences in motivation. At the point of behavioral stability, determined 
by no choice variation greater than 25% over the course of 6 consecutive testing days 
when comparing across discrete delay intervals, the reversal phase commenced. The 
number of sessions required to reach behavioral stability was recorded. 
 
Behavioral Data Analysis 
Behavioral data was analyzed using a two-way ANOVA followed by Dunnett’s 
test in order to compare each group to controls, and LSD analysis for general group 
comparisons.  
Immunohistochemistry 
Whole brains were extracted approximately 90 minutes following behavioral 
testing. Rats were first euthanized with Sleep Away (0.5 mg/kg i.p. [26.0% sodium 
pentobarbital in 7.8% isopropyl alcohol and 20.7% propylene glycol], Fort Dodge Animal 
Health, Fort Dodge, IA) and transcardially perfused (Masterflux Cole-Parmer Instrument 
Company, Trumpers Way, London) with a saline solution (9%) followed by a 4% 
paraformaldehyde solution (in 0.1 M PBS). Brains were post fixed in 4% 
paraformaldehyde followed by immersion into a 30% sucrose solution. Tissue was sliced 
on a freezing sliding microtome (Leica SM2000R, Munich, Germany) at 40 uM and 
stored in cryoprotectant at -20 degrees C in preparation for immunohistochemistry to 
assess Arc and NeuN staining, and Cavalieri volumetric analysis. 
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NeuN Staining 
 Slice selection commenced at the most anterior sample collected containing the 
areas of interest (OFC, IL and PL, between 5.64 and 4.20 from Bregma, according to 
Paxinos and Watson, 1982). Every 5th section was collected for staining. Sections were 
rinsed 3 times in TBS for 5 minutes each at room temperature (RT). (Note: Adapted from 
Cold Spring Harbor Protocols (2009); 50mM Tris-Cl and 150mM NaCl (pH 7.5 +/-.02)). 
Subsequently, sections were rinsed in a 0.3 % Hydrogen Peroxide solution for 30 
minutes at room temperature. Then sections were again rinsed 3 times for 5 minutes in 
tris-buffered saline (TBS) at RT and blocked with Normal Horse Serum (NHS) (Vector 
Labs (S-2000) Burlingame, CA, USA).  Following this step, slices were rinsed for another 
3 cycles in TBS for 5 minutes each at room temperature and incubated in NeuN primary 
antibody monoclonal mouse anti-NeuN (Millipore (MAB337; Billerica, MA) for 48 hours at 
4 degrees C (1:500). Sections were again rinsed 3 times in TBS for 5 minutes each, then 
incubated in secondary antibody biotinylated horse anti-mouse IgG (Vector Labs; BA-
2001). Following this step, slices were incubated in ABC solution (ABC Elite kit standard 
Vector Labs) at room temperature for 120 minutes then rinsed again for another 3 cycles 
in TBS for 5 minutes each. Slices were then immersed in 3,3’-Diaminobenzidine (DAB 
substrate kit, Sigma Aldrich) for visualization for approximately 3 minutes, a time period 
determined by the color of the chromagen (DAB). Finally, slices were washed for 
another three 10 minute cycles in TBS prior to mounting on slides. Slices were left to dry 
overnight and coverslipped using Paramount (Fisher Chemicals, Hampton, NH). 
Arc Staining 
This procedure is adapted from Chia & Otto. (2013).  Sections were washed 3 
times in phosphate buffered saline (PBS) for 10 minutes each at room temperature and 
subsequently blocked in 1% Bovine Serum Albumin (BSA) in PBS + (0.1% Triton-X) at 
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room temperature for 1 hour. Following this step, slices were incubated in Primary rabbit 
polyclonal Arc 1:1000 (Synaptic Systems, Goettingen, Germany). Thereafter, sections 
were washed 3 times in PBS for 10 minutes and incubated in secondary solution 
(Vector-Vectastain ABC kit (PK-6012)) anti-mouse at room temperature for 1 hour. 
Afterwards, sections were again washed 3 times for 10 minutes each in PBS prior to 
immersion in 3,3’-Diaminobenzidine (DAB substrate kit Sigma Aldrich St. Louis) solution 
for visualization (approximately 3 minutes). Finally, slices were washed for another three 
10 minute cycles in PBS prior to mounting on slides. Slices were left to dry overnight and 
coverslipped using Paramount (Fisher Chemicals). 
Cavalieri Volumetric Analysis (CVA) 
 Mounted 40 micron slices of NeuN stained tissue were examined using a Zeiss 
Axioskop 2 plus microscope (Oberkochen, Germany) and CX9000 MBF Bioscience 
camera (Willeston, VT), and analyzed using StereoInvestigator MBF Biosciences. 
Sections were determined using a systematic sampling technique in which there was 
analysis of equidistant sections commencing with the last section collected at the 
confluence of the corpus callosum (Examples of region determination for volumetric 
analysis of the OFC and PL/IL can be seen in Figure 2) in which the region of interest 
last appears in a randomly chosen pre-collected series continuing for every 5th section 
until 9 sections of orbitofrontal and 4 sections from the limbic cortex were analyzed for 
each subject. These slices ranged from 2.52 to 4.20 from Bregma (Paxinos and Watson, 
1982). CVA data was analyzed using a univariate ANOVA followed by a Dunnet’s test to 
compare each group to controls, as well as LSD tests to compare across groups more 
broadly. 
Interventricular Distances (IVD) Measures 
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In addition to quantitative analysis of cortical volumes, measures of 
interventricular distances were taken as a metric of thalamic shrinkage (Robinson & 
Mair, 1992; Hall & Savage, 2016). This was completed by measuring the distance from 
the floor of the dorsal third ventricle to the top of the third ventricle at three locations (-
2.76mm, -3.24mm, -3.60mm from Bregma according to Paxinos and Watson, 1986) 
thereby measuring the size of the thalamus. IVDs were analyzed using a univariate 
ANOVA. Additionally, Pearson’s correlations were done to analyze the relationship 
between IVDs and delay discounting behavior. 
Cell Counting 
 Arc stained slices were counted at 7.6X magnification to evaluate cellular activity 
in the medial and lateral orbitofrontal cortices as well as the prelimbic and infralimbic 
regions. ROIs were .8 x .6 mm and omitted the neuron sparse plexiform layer of the 
cortex (see Figure 3 for an exemplar). Slices were determined using the sampling 
technique described in the CVA section and analyzed using ImageJ to automatically 
count the regions depicted using a Nikon Optishot-2 microscope (Melville, NY) equipped 
with an Infinity HD Lumenera camera (Nepan, ON, Canada). Counts were analyzed 
based on anterior and posterior orientation using a repeated measures ANOVA and 
Dunnett’s test as well as by individual slice using LSD analysis to compare across all 
groups. 
Results 
Treatment Data: 
 Weight: There were overall differences in weights across groups (F(5,55)=5.286, 
p<.05). PF subjects had a greater average body weight (544.79 g) than CET-TH (455.96 
g) and CET-PTD (457.70 g) animals (p<.05) (Figure 4).  
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Consumption: There were no significant differences in liquid consumption by 
body weight across ethanol treated groups (CET; CET-Th; CET-PTD) (F(2, 29)=3.064, 
p>.05) (Figure 5). 
BEC: Blood ethanol concentration data analysis did not show any significant 
differences across ethanol treated groups (Figure 6 A-C). All ethanol treated groups 
were significantly higher than PF, the ethanol naïve control group (F(3,28)=28.321, 
p<.001). In Month 1 all CET groups had means above 34 g/kg, this increased to means 
above 45 g/kg in Month 2/3, rising again in Month 4 to means above 70 g/kg, at which 
point there seems to be a ceiling effect with means topping out at above 85 mg/dl. This 
effect of time was significant for all groups (F(3, 28)=28.321, p<.001). 
Behavioral Data 
Phase 1: Initial Acquisition (Delay Discounting) 
 There were significant group differences in the number of days required to reach 
stability on the Delay Discounting task (Figure 7 A) (Main effect of treatment (F(5, 
43)=3.33, p<.05). Dunnett’s test revealed that CET and CET-Th groups took significantly 
longer than PF controls to reach criterion.  
Exploratory Analysis  
Exploratory post hoc LSD analysis showed differences between PF and CET 
(p<.01), CET-TH (p<.01), CET-PTD (P<.05), and PTD-EAS (P<.05) illustrating that these 
treatment groups took significantly more days to attain the behavioral stability criterion 
than PF (Figure 7 A). Although PTD-MAS subjects did not differ significantly from PF 
animals, they exhibited greater variability as expressed by their standard deviation. 
 Delay Discounting 
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A significant overall effect of Treatment was seen (F(5,43)=2.21, p< 0.028). In 
addition there was a general effect of Delay (F=4,172)=74.14, p<.001). There was a 
significant Treatment x Delay interaction (F(20,172)=2.01, p<.05) (Figure 7 B). Dunnett’s 
test revealed that there was a slight trend toward fewer delay lever choices in CET 
treated groups (p=.080) and a significant reduction in PTD-MAS subjects (p<.05) when 
compared to PF controls. Additionally, when examining discrete delay points there was 
no significant difference at the 0 second time point (F(5, 49)=1.169, p>.05); at the 10 
second delay there was no significant difference between groups (F(5, 49)=2.081, 
p>.05). However there was a significant reduction in the preference for the delay lever in 
PTD-MAS subjects at this time point as compared to controls using the Dunnett’s test 
(p<.05); at the 20 second time point there were no significant differences overall 
(F(5,49)=2.238, p>.05), however again Dunnett’s post hoc analysis revealed a significant 
difference in PTD-MAS animals delay lever choices demonstrating a reduction as 
compared to controls (p<.05); at the 40 second delay point there was a significant effect 
of delay overall (F(5,49)=3.014, p<.05) as well as a significant reduction in delay lever 
preference in PTD-MAS subjects as compared to PFs using the Dunnett’s test (p<.01); 
finally, at the 60 second time point there was a significant effect of delay (F(5,49)=3.385, 
p<.05) as well as a significant reduction in delay lever choice behavior in the PTD-MAS 
(p<.01) and CET treated (p<.05) animals as compared to controls revealed by the 
Dunnett’s test. There were no significant differences among other groups (p>.05). 
Exploratory LSD: 
Exploratory post hoc LSD (which allows for comparisons across all groups as 
opposed to controls as in the Dunnett’s test) analysis shows differences between groups 
at several delay intervals. PF rats are significantly different from rats in the CET and 
CET-TH groups at 0-s delay (both F’s(1, 13)=5.879, p<.05). At the 10-s, 20-s and 40-s 
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delay intervals only the PTD-MAS group differed from PF controls (F(1, 15)=5.907, 
p’s<.05). Furthermore at the 60-delay interval both the CET and PTD-MAS groups were 
different from PF controls (both F’s(1,15),(1,14))=5.880, p’s<.01). The PTD-MAS 
subjects differ from PF controls starting at every protracted delay point, demonstrating a 
more pronounced increase in impulsive choice behavior, as described in order of 
increasing delay in the following paragraph.  Neither the PTD-EAS or the CET-Th groups 
differed from the PF control group at any delay interval. Because of the potential, 
indicated by work from the lab previously discussed, for thiamine supplementation to 
prevent the effects of CET and the potential differences between CET and PTD treated 
groups, these metrics were also analyzed. Based on these analyses further testing may 
be warranted. There were no significant differences among other treatment groups 
(p>.05) (Figure 7 B). 
Nose Poke Omissions 
An additional metric observed, nose poke omissions, constitute the failure of an 
animal to initiate the trial. There were no Treatment X Delay interactions (F(20, 
168)=0.92, p<.3). There was an effect of Delay (F(4,268)=13.75, p<.05).There were no 
significant differences across groups during the stability phase of the initial delay 
discounting task (F(5,42)=.618,p>.05). (Figure 7 C and D) 
Lever Omissions 
A final metric, lever omissions, deemed a subject’s failure to press a lever and 
thereby make a choice, showed no significant effects of Treatment during the last 6 days 
for delay discounting (F(5,42)=1.471, p>.05). There was an effect of Delay 
(F(4,168)=2.45, p<.05). There was no Treatment X Delay interaction (F(20, 168)=1.14, 
p<.3) (Figure 7 E and F). 
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Phase 2: Switched Contingencies (Reversal Learning) 
There were no differences across treatment conditions during the Reversal 
Learning Phase, defined as the first six days after the change in reward contingencies 
(F(11.175)=.817, p>.05) (Figure 8 A and B). 
Lever Omissions 
There were no significant differences (5,42)=.269, p>.05) in lever omissions 
across groups (Figure 8 C and D). 
 Nose Poke Omissions 
 There were no significant differences (F5,43)=1.45, p>.05) in nose poke 
omissions across groups (Figure 8 E and F). 
 
Task Reacquisition 
Time to behavioral stability during the Reversal Delay Discounting was not 
different across the treatment conditions (F(5,40)=1.609, p>.05) (Figure 9 A). 
Additionally, Dunnett’s test revealed no significant differences across groups as 
compared to PF controls (all p’s >.05). 
Stable Performance: 
Reversal Delay Discounting 
The reversed delay discounting curves were attenuated by previous exposure to 
the task resulting in an effect of delay (F(1.89, 77.57)=120.131, p<.001) (adjusted for 
sphericity violation using Greenhouse-Guiesser) and no effect of treatment 
28 
 
(F(5,41)=.757, p>.05). Dunnett’s test did not reveal any significant differences in 
treatment groups as compared to PF controls (p>.05) (Figure 9 B) 
Exploratory Analysis: 
 LSD analysis showed that there was a difference between PF and PTD-MAS 
treatments at the 20 second time point, PTD-MAS rats were more impulsive than PF 
subjects (F(1, 17 )=4.612, p<.05) (as noted in Figure 9 B). 
Nose Poke Omissions 
There were no significant Treatment differences in nose poke omissions across 
groups during the stability phase of the reversal phase delay discounting task 
(F(5,42)=1.45,p>.05). There were no Treatment X Delay interactions (F(10.17, 
87.07)=1.08, P>.05). There was an effect of Delay (F(2.02, 87.007)=23.39, p<.0001). 
(Figure 9 C and D). 
Lever Omissions 
Finally, there were no significant effects of treatment on lever omissions during 
the reversal phase of discounting (F(5,42)=0.741,p>.05) There was also no effect of 
Delay (F(3.03, 127.23)=1.41, p>.15) (Figure 9 E and F). 
Histological Data 
Interventricular Distances 
 There was no main effect of IVDs over all treatment groups (F(5,30)=2.07,p>.05). 
(Figure 10). However, Dunnett’s test revealed that the IVD of CE T-PTD subjects were 
significantly reduced as compared to PFs (p<.05). 
 Exploratory IVD and Behavioral Correlations 
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 Phase 1: Delay Discounting  
 Pearson’s r revealed no correlation between IVD and delay discounting behavior 
at any time point. At 0 delay (r=-.234, n=25, p=.130); at 10 seconds (r=-.038, n= 25, p= 
.429); at 20 seconds (r=-.047, n=25, p=.412); at 40 seconds (r=-.056, n=25, p=.395) and 
at 60 seconds (r=-.054, n=25, p=.398). (Figure 11) 
 Phase 2: Reversal Learning  
Pearson’s r revealed no correlation between IVD and delay discounting behavior 
at any time point. At 0 delay (r=.319, n=25, p=.060); at 10 seconds (r=.012, n=25, 
p=.478); at 20 seconds (r=-.066, n=25, p=.377); at 40 seconds (r=-.188, n=25, p=.184) 
and at 60 seconds (r=-.090, n=25, p=.334). (Figure 12) 
Cavalieri Volumetric Analysis 
 Orbitofrontal Cortex 
There were no significant differences in cortical volume in the OFC across 
groups (F(5,38)=.287, p=.919) (Figure 13).  
Limbic Cortex 
There were no significant differences in limbic volumes across groups in the 
limbic cortex (F(5,38)=1.366, p=.259) (Figure 14). Dunnett’s test revealed no significant 
differences in any groups as compared to PF controls (all p’s greater than .05). 
 
Exploratory Analysis 
Although there were no significant differences in orbitofrontal cortical volumes 
across groups (all p’s>.05), LSD comparative analysis of limbic cortical volume revealed 
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a significant increase in volume in CET subjects as compared to PF animals (p=.015). 
Additionally, there was a trend (p=.06) toward larger limbic volumes in CET animals as 
compared to those with thiamine supplementation (CET-TH) (Figure 14). 
Cellular Activity 
Medial OFC Activity 
 Cellular activity in the medial OFC (Figure 15 and 16) was not significantly 
different overall across treatment groups (F(5, 33)=.332, p=.890). However, there was a 
significant effect of anterior versus posterior regions which revealed higher Arc 
immunoreactivity in the posterior region of the mOFC in all groups (F=1,33)=31.130, 
p<.01). Dunnett’s test revealed that there were no significant differences in any 
treatment groups as compared to PF controls (all p’s >.05). 
Exploratory Analysis: Medial OFC 
Slices were also analyzed individually to inform further analysis, those with 
significant differences are reported here. For Slice 8:  there were no overall differences 
(F(5,1)=1.237, p=.166), again the PF subjects exhibited more cellular activity than CET 
subjects (p=.042) and PTD-EAS animals (p=.042) (Figure 17). Additionally, for Slice 9 
(Figure 18): there were no overall differences (F(5,1)=1.077, p=.394), yet there was still 
a significant decrease in cellular activity in CET animals as compared to PFs (p=.037) 
(Figures 17 and 18). 
Lateral OFC Activity  
Arc immunoreative cell counting revealed that there were no overall significant 
differences in the lateral OFC across groups (F(5, 31)=.535, p=.748). However, there 
were still differences across the anterior (Figure 19) versus posterior (Figure 20) axis 
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with significantly greater overall Arc immunoreactivity in the posterior region (F=(5, 
31)=28.688, p<.01). Dunnett’s test found that there were no significant differences in 
treatment groups as compared to controls (all p’s >.05).  
  
Exploratory Analysis: Lateral OFC 
 LSD analysis revealed that there were differences in cellular activity in posterior 
slices, which will be discussed specifically. For Slice 7 (Figure 21): PF groups had more 
active cells than CET (p=.018), PTD-EAS (p=.010), and PTD-MAS (p=.010), additionally 
there was a trend toward more activity in PFs compared to both the CET-PTD subjects 
(p=.082) and CET-TH animals (p=.055). For Slice 8 (Figure 22):  there were no overall 
significant differences [F(5,1)=2.011, p=.106] however PF subjects had significantly 
more cellular activity than all treatment groups; CET (p=.020); CET-PTD (p=.034); CET-
TH (p=.019); PTD-EAS (p=.010); PTD-MAS (p=.014).  Finally, in Slice 9 (Figure 23): 
there were no overall significant differences (F(5,1), p=.085) though PF animals again 
had higher cellular activity than other groups; CET-PTD (p=.007); CET-TH (p=.042); 
PTD-EAS (p=.010); PTD-MAS (p=.014). In this case, there was also a trend toward PFs 
having higher activity than CET subjects (p=.076).  
Infralimbic Cortex  
There were no overall differences in Arc immunoreactivity in the infralimbic cortex 
(F(5,31)=.853, p=.524), however there were significant differences across the anterior-
posterior axis; the anterior portions again had greater Arc immunoreactivity 
(F(1,30)=14.869, p<.01). Dunnett’s test revealed that there were no significant 
differences in treatment groups as compared to PFs (all p’s>.05) (Figures 24 and 25). 
 Exploratory Analysis: Infralimbic Activity 
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In the case of the infralimbic cortex (Figure 26) in Slice 3: although there were no 
overall differences (F(5,1)=.264, p=.264) there was significantly reduced activity in the 
PTD-EAS subjects as compared to PFs (p=.038). In Slice 4 (Figure 27): there were no 
significant overall differences across groups (F(5,1) =1.037, p=.414), however due to a 
reduction of activity in PTD-EAS animals, and an increase in PTD-MAS subjects as 
compared to PFs, there was a strong trend (p=.051) according to LSD analysis. 
Prelimbic Cortex 
There were no overall differences in Arc staining in the prelimbic cortex across 
treatment groups (F(5,31)=504, p=.771). However, again there were significantly more 
Arc positive cells in the anterior regions (F(1,30)=411,420, p=.019). Dunnett’s test 
revealed no significant differences across groups when compared to PFs (all p’s>.05) 
(Figures 28 and 29). 
 Exploratory Analysis: Prelimbic Activity  
In the prelimbic cortex (Figure 30) there was again differential cellular activity in 
the anterior region. In Slice 1: there were no overall differences (F(5,1)=1.086, p=.390), 
and PF animals had significantly more cellular activity than PTD-MAS subjects (p=.046). 
Discussion 
The differential delay discounting curves demonstrated by CET and PTD-MAS 
animals indicate that both of these treatments result in increased impulsive choice 
behavior. Additionally, post reversal delay discounting curves demonstrated that this 
behavior can be ‘trained out’ (reduced) with task exposure in CET subjects. That is to 
say that, with practice, these impulsive choice tendencies can be ameliorated. An 
important difference is that in PTD-MAS subjects there was an increase in impulsive 
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behavior in the initial delay discounting task and this impulsivity may not be alleviated by 
training during the post reversal phase as indicated by exploratory LSD analysis.  
Another key point is that the animals exposed to chronic ethanol that received 
thiamine supplementation (CET-Th) did not develop an impulsive phenotype. 
Additionally, there is a non-significant, but visible, downward shift in the discounting 
curve of subjects with milder thiamine deficiency (PTD-EAS) indicating a possibility that 
mild thiamine deficiency could lead to a slightly more impulsive tendency, which 
combined with CET, but not seen in CET-PTD, could result in significant differences in 
impulsive choice behavior. 
 However, as illustrated in figures 11 and 12, in this study the CET-PTD subjects 
demonstrated a unique phenotype with potential subpopulations with dissimilar 
approaches to the task. This may be due to differences in neuropathology induced by 
these comorbid treatments, an avenue for further investigation. Although there were not 
statistically significant differences in CET-PTD subjects’ delay discounting curves from 
those of PF subjects, this seems to have changed when examined with regard to IVD or 
thalamic pathology. Subjects with reduced interventricular distance had a pattern of 
slightly higher, though non-significant, levels of impulsivity than members of their group 
whose IVDs were not two standard deviations below the mean of the PF group in the 
initial delay discounting phase (Figure 11). This difference persisted during the reversal 
phase as well (Figure 12), though there were no observable differences by the 60 
second time point in this case.  
Additionally, PTD-EAS subjects also exhibited this behavioral dichotomy when 
compared based on IVD, illustrating a distinct difference in these two ‘subpopulations’ 
during the initial delay discounting phase (Figure 11) with those with thalamic pathology 
being more impulsive. These observations suggest that thalamic damage is associated 
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with the generation of the pervasive impulsive phenotype. Importantly, thalamic lesions 
(a hallmark of WKS) which induce reductions in IVD are a direct consequence of 
thiamine deficiency (for review see Savage, 2014), further implicating this nutritional 
deficiency in the production of the impulsive phenotype. 
Volumetric data indicated that there is a significant increase in the volume of the 
limbic cortex, but not OFC, in CET animals compared to PF, based on LSD analysis. 
This could be due to a compensatory or inflammatory response to chronic ethanol 
treatment. Additionally, there was a trend toward larger limbic volumes in the CET group 
as compared to CET-Th animals which should be noted. This may indicate that this 
increase can be prevented with thiamine supplementation. Although there is established 
evidence that chronic ethanol exposure can result in cortical shrinkage, there is also 
differential vulnerability to ethanol exposure across brain regions (Archibald, Fennema-
Notestine, Gamst, Riley, Mattson, and Jernigan, 2001; for review see Butterworth, 2003; 
for review see Goodlett, and Horn, 2001; for review see Sullivan and Pfefferbaum, 2005; 
Volkow and Fowler, 2000; Ridderinkhof, Vlut, Bramlage, Spaan, Elton, Snel, and Band, 
2002). Because volumetric analysis in this study encapsulated each region from anterior 
to posterior as well as medial to lateral as a single data point, regional differences across 
the tissue may not have been evident in the overall analysis. Therefore, further studies 
could address the possibility that shrinkage in these regions is selective across these 
dimensions, and if some regions increase in volume due to a compensatory mechanism 
as may be suggested in our exploratory analysis in the case of CET subjects.  
This point is furthered by the IHC data observing cellular activity using the 
immediate early gene Arc, according to ANOVA (anterior-posterior differences) and 
exploratory (LSD) analysis. Although these were low powered analyses, and are therefor 
highly speculative, we observed a significant decrease in cellular activity in the posterior 
35 
 
orbitofrontal cortex of all treatment groups compared to controls. In the limbic cortices, 
however, differences were seen in the more anterior regions in the PTD-MAS animals as 
compared to all other groups. This could be an artifact of region specific vulnerability that 
could be explored in future work. 
Importantly, however, this differential cellular activity is also consistent with past 
literature, which informed the decision to conduct post hoc analyses in this study, that 
indicates functional specificity within the anterior-posterior and medial-lateral axis of the 
OFC. Studies have demonstrated that the medial OFC is implicated in the processing of 
reward value, while the lateral portion is involved in punishment evaluation (for meta-
analysis and review see Kringlebach and Rolls, 2004; O’Doherty, Kringlebach, Rolls, 
Hornak, and Andrews, 2001). Differences in medial OFC activity demonstrated in the 
most posterior, 8th and 9th, slices of the CET subjects, significantly less than PF, may 
indicate a deficit or alteration in the processing of reward value. Also consistent with the 
literature is the posterior location of these differences, as this region is implicated in the 
processing of simple rewards (e.g., food) as opposed to the anterior region which 
processes complex or learned rewards (e.g., cue, money) (for meta-analysis and review 
see Kringlebach and Rolls, 2004; O’Doherty et al., 2001; De Araujo, Kringlebach, Rolls, 
and McGlone, 2003b; De Araujo, Kringlebach, Rolls, McGlone, and Phillips, 2003c). 
It is important to note that the Arc immunoreactivity indicating cellular activity 
monitored in this study is specific to cellular activity at the 60 second time point, because 
subjects were sacrificed at the culmination of their last day of stability (or at ceiling) 90 
minutes after completion. This is the critical window for optimal Arc immunoreactivity 
(Lonergan, Gafford, Jarome, and Helmsetter, 2010); however, it only demonstrates the 
most recent activity. Because of the 60 second delay most recently presented to the 
animals, there could have been reduced cellular activity inherent to that phase of the 
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task, as 41% of neurons in the OFC fire in response to rewards received after a short 
delay, whereas only 17% respond in anticipation of delayed rewards. This means that 
there is inherently more activity for short delay rewards (Roesch, Taylor, and 
Schoenbaum, 2006). However, at the 60 second time point there were no statistically 
significant differences between groups indicating that this differential activity may be due 
to reward processing differences rather than exposure to delay, because all subjects 
were choosing the small delay for the immediate reward. 
Because in this study we observed, according to limited exploratory analysis, that 
there was significantly more cellular activity in the posterior three sections of the lateral 
OFC, with the PF subjects displaying significantly more activity, there may be an 
alteration in the processing of the aversive effects of delay (if considered punishing) 
across all treatment groups. 
Based on both behavioral and histological data, there is a possibility that 
thiamine supplementation could slow or ameliorate the effects of chronic alcohol 
exposure on choice impulsivity and potentially rescue some of the neuropathological 
changes that occur in instances of chronic alcohol consumption. For example, there is a 
visually evident, though non-significant, increase in impulsivity in the CET-Th group as 
evidenced in the apparent increase in slope during delay discounting. This may indicate 
that the progression of developing an impulsive phenotype is partially due to thiamine 
deficiency because of the malabsorption of nutrients induced by chronic alcohol 
consumption which seems to be slowed by thiamine supplementation. Bolstering this 
argument is the apparent change in the behavior of the PTD-EAS subjects toward a 
more impulsive phenotype, though not significantly different from PF animals. 
Importantly, excessive thiamine deficiency at the level seen in the PTD-MAS animals not 
only results in an impulsive phenotype, these subjects become more impulsive than 
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those with chronic alcohol exposure alone and the ‘practice effects’ due to protracted 
task exposure seen in CET subjects are absent from this group. This indicates that there 
is a more persistent change in impulsive choice behavior that is dependent on thiamine 
deficiency. 
An additional point that warrants further investigation is the role of the limbic 
cortex in the pervasive impulsive phenotype exhibited by the PTD-MAS group. This was 
the only group that retained impulsive decision making behavior after excessive training. 
They were also unique in their differential activity in the anterior portion of this region, 
specifically the anterior prelimbic cortex. Because of this, the limbic cortical insults may 
be critical in prolonged impulsive choice behavior. The differences in PTD-EAS cellular 
activity in this region may have been driven by subjects in the low IVD ‘subpopulation’, 
another point of further investigation. 
The results observed in the CET-Th group demonstrated attenuated levels of 
impulsivity and no significant differences from PF controls on neurohistological 
assessments. This indicates a protective effect of thiamine supplementation in chronic 
ethanol exposure. As discussed by Martin et al. (2003), chronic alcohol exposure can 
culminate in an inadequate uptake of thiamine due to decreased absorption in the 
gastrointestinal tract (Martin, Singleton and Hiller-Sturmhofel, 2003; for review see 
Hoyumpa, 1980). Although in this study nutritional uptake was not measured (a potential 
avenue for further investigation), there are two mechanisms involved. These were 
discussed by Hoyumpa (1980); first a reduction in gastric absorption, and therefore a 
potential for reduced thiamine intake into cells, and secondly impaired cellular utilization 
of nutrients, in this case thiamine, may have been a factor in our CET groups. This may 
have been prevented by thiamine supplementation in the CET-Th group, attenuating the 
negative side effects of alcohol induced thiamine deficiency. Additionally, in animal 
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studies it has been demonstrated that when thiamine is in low concentrations active 
transport is necessary for thiamine to traverse the cellular membrane. In higher 
concentrations, there is a chemical gradient which allows for passive transport of the 
molecule into the cell (for review see Martin et al., 2003, Hoyumpa, 1980). This 
differential mechanism may play a role in allowing for thiamine absorption in the CET-Th 
subjects. However, this was not explored in this study and leaves another venue open 
for investigation. Another factor may have been differences in food consumption across 
both this group, as well as CET-PTD, as compared to PF subjects, who weighed 
significantly more on average (Figure 4). 
 This research bolsters previous studies which have indicated that thiamine 
supplementation may be beneficial in cases of chronic alcohol consumption. For 
example, studies exploring the effect of thiamine supplementation administered to 
chronically ethanol treated lab animals and alcoholic human patients have demonstrated 
that this treatment ameliorated both metabolic and behavioral consequences of alcohol 
induced thiamine deficiency (Lee, Tarter, Holburn, Price, Winestein and Martin, 1995; 
Victor, Addams, and Collins, 1989). Additionally, experiments examining the effects of 
thiamine supplementation on human subjects in recovery have demonstrated that the 
most benefit is garnered from high dose thiamine treatment when considering working 
memory performance (Ambrose, Bowden, and Whelan, 2001). 
 In line with these investigations, the use of thiamine supplementation as a 
prophylactic treatment has been recommended in the past. It has been suggested that 
preventative thiamine supplementation of 250 mg IM should be administered to at risk 
patients (Cook and Thomson, 1997; Thomson and Cook, 1997; Cook, 2000; Thomson, 
2000; Hope, Cook and Thomson, 1999). Prophylactic thiamine treatment has also been 
suggested by Bligh and Madden (1983). Our current study bolsters this argument by 
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demonstrating that thiamine supplementation concomitant with alcohol exposure 
ameliorates the chronic alcohol induced impulsive phenotype as well as the 
neuropathological changes seen in this treatment group. 
This study also provides justification to investigate potential prophylactic 
treatments for alcoholics or those in treatment to prevent further neurological insult. 
Additionally, we have demonstrated separable, but linked, roles for the OFC and limbic 
cortices that provide a foundation for further inquiry.  
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Figure 1. Treatment and behavioral testing timeline depicting chronic ethanol and PTD 
treatment, blood sample collection, recovery, and behavioral testing. 
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Figure 2. Example regions for Cavalieri Volumetric Analysis of the orbitofrontal cortex 
(OFC), prelimbic (PL), and infralimbic (IL) cortices on representative NeuN stained 
frontal tissue. 
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Figure 3: Example regions for Arc immunoreactive cellular counting analysis of medial 
and lateral OFC (mOFC and lOFC) as well as prelimbic and infralimbic cortex (PL and 
IL). All regions were .8 x .6 mm. 
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Figure 4. Average weights for PF and ethanol treated groups across the period of 
ethanol treatment encompassing fade on and fade off demonstrate no differences. (n per 
group: PF=8; CET=8; CET-TH=8; CET-PTD=9) 
 
 
 
 
 
 
 
 
 
0
200
400
600
800
1000
WE
IGH
T (
G)
WEEKS
ANIMAL WEIGHTS
44 
 
A 
 
B 
 
C 
 
Figure 5. A) Ethanol consumed in g/kg body weight for PF subjects and all CET groups.  
B) Weeks 1-3 encompass the ‘Fade On’ portion of CET titrating up from 0 (6%, 9%, 12% 
EtOH), C) Weeks 29-31 are the ‘Fade Off’ of treatment prior to recovery. (n per group: 
PF=8; CET=8; CET-TH=8; CET-PTD=9) 
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Figure 6. BEC levels measured at months 1, 2/3, 4, and 6 were not different as a 
function of group within CET treated animals. However, the BECs of rats exposed to 
EtOH increased across time. The BECs from these groups were significantly above PF 
rats given water. (n per group: PF=8; CET=8; CET-TH=8; CET-PTD=9) 
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A. Days to Reach Criterion  B. Delayed Discounting Curve (Last 6 Days) 
     
C. Nose Poke Omissions by Delay             D. Nose Poke Omission Averages 
 
E. Lever Omissions by Delay   F. Lever Omission Averages 
 
Figure 7. A). Days to reach behavioral stability during initial delay discounting phase. B) 
Delay lever choice behavior (%) across increasing delays (s) C) Nose poke omissions 
across increasing time points. D) Average nose poke omissions during the last 6 days of 
delay discounting. E) Lever omissions by delay. F) Average lever omissions. (n per 
group: PF=8; CET=8; CET-TH=8; CET-PTD=7; PTD-EAS=9; PTD-MAS=9) 
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A. Reversal Average Delay Lever Choice B. Reversal-First 6 Days 
       
    C. Lever Omissions by Delay   D. Lever Omission Averages 
 
E. Nose Poke Omissions by Delay   F. Nose Poke Omission Averages 
 
Figure 8. A). Days to reach behavioral stability. B) Delay lever choice behavior (%) 
across increasing delays (s) (*) indicate significant differences from PF at a particular 
time point). C.) Lever omissions by delay D.) Average lever omissions E.) Nose poke 
omissions across increasing time points illustrating that PTD-MAS and CET-Th rats are 
less likely to fail to initiate trials F). Average nose poke omissions during reversal 
learning phase. (n per group: PF=8; CET=8; CET-TH=8; CET-PTD=7; PTD-EAS=8; 
PTD-MAS=10) 
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A. Days to Reach Reversal Criterion          B. Post-Reversal Delay Discounting Curve 
  
C. Nose Poke Omissions by Delay             D. Nose Poke Omission Averages 
 
E. Lever Omissions by Delay   F. Lever Omission Averages 
 
Figure 9. A). Days to reach reversal phase delay discounting stability criterion (ie: 
behavioral stability). B) Delay lever choice behavior (%) across increasing delays (s) (* 
indicate significant differences from PF at a specific time point). C) Nose poke omissions 
across increasing time points. D) Average nose poke omissions during the last 6 days of 
delay discounting. E.) Lever omissions as delay to reward increases F.) Average lever 
omissions by treatment. (n per group: PF=8; CET=7; CET-TH=7; CET-PTD=7; PTD-
EAS=9; PTD-MAS=9) 
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Figure 10. Average interventricular distance demonstrating reductions (n.s.) in PTD-EAS 
and PTD-MAS treatment groups and significant reductions in CET-PTD rats. (n per 
group: PF=6; CET=7; CET-TH=3; CET-PTD=6; PTD-EAS=7; PTD-MAS=7) 
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Figure 11. Initial phase delay discounting curves with PTD subjects parsed based on 
interventricular distance (IVD). Groups designated ‘sm’ have IVDs 2 standard deviations 
below the mean of PF treated animals. (n per group: PF=8; CET=7; CET-TH=7; CET-
PTD=3; PTD-EAS=6; PTD-MAS=7; C-P Sm=3; EAS Sm=2; MAS Sm=2) 
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Figure 12. Reversal phase delay discounting curves with PTD subjects parsed based on 
interventricular distance. Groups designated ‘sm’ have IVDs 2 standard deviations below 
the mean of PF treated animals. (n per group: PF=8; CET=7; CET-TH=7; CET-PTD=3; 
PTD-EAS=6; PTD-MAS=7; C-P (CET-PTD) Sm=3; EAS Sm=2; MAS Sm=2) 
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Figure 13. Cavalieri volumetric analysis of orbitofrontal cortex volumes demonstrating no 
differences across groups. (n per group: PF=7; CET=7; CET-TH=6; CET-PTD=7; PTD-
EAS=8; PTD-MAS=9) 
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Figure 14. Cavalieri volumetric analysis of limbic cortex volume demonstrating increased 
volume in the CET group as compared to PF animals. (n per group: PF=7; CET=6; CET-
TH=7; CET-PTD=7; PTD-EAS=8; PTD-MAS=9) 
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Figure 15. Average anterior Arc immunoreactive cells in the antero-medial orbitofrontal 
cortex. (n per group: PF=5; CET=5; CET-TH=4; CET-PTD=4; PTD-EAS=5; PTD-
MAS=4) 
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Figure 16. Average Arc immunoreactivity in postero-medial orbitofrontal cortex neurons. 
(n per group: PF=5; CET=5; CET-TH=4; CET-PTD=4; PTD-EAS=5; PTD-MAS=4) 
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Figure 17. Arc immunoreactive cell counts indicating higher cellular activity in PFs as 
compared to CET and PTD-EAS subjects. (n per group: PF=5; CET=6; CET-TH=7; CET-
PTD=5; PTD-EAS=7; PTD-MAS=7) 
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Figure 18. Active cell counts demonstrating decreased cellular activity in CET subjects 
as compared to PFs. (n per group: PF=5; CET=5; CET-TH=5; CET-PTD=6; PTD-
EAS=8; PTD-MAS=6) 
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Figure 19. Average antero-lateral orbitofrontal cortex Arc immunoreactivity. (n per group: 
PF=4; CET=3; CET-TH=3; CET-PTD=4; PTD-EAS=7; PTD-MAS=4) 
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Figure 20. Average postero-lateral orbitofrontal cortical Arc immunoreactivity. (n per 
group: PF=4; CET=3; CET-TH=3; CET-PTD=4; PTD-EAS=7; PTD-MAS=4) 
  
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
PF CET CET‐TH CET‐PTD PTD‐EAS PTD‐MAS
Ac
tiv
e C
ells
Average Posterior Arc Activity lOFC
60 
 
 
Figure 21. Cellular activity counts demonstrating higher activity in PF animals as 
compared to other groups. (n per group: PF=5; CET=5; CET-TH=5; CET-PTD=6; PTD-
EAS=8; PTD-MAS=7) 
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Figure 22. Counts of active cells demonstrating that PFs had higher cellular activity as 
compared to all other groups. (n per group: PF=5; CET=6; CET-TH=5; CET-PTD=6; 
PTD-EAS=7; PTD-MAS=7) 
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Figure 23. Counts of active cells demonstrating that PFs had higher cellular activity as 
compared to all other groups. (n per group: PF=5; CET=3; CET-TH=5; CET-PTD=6; 
PTD-EAS=8; PTD-MAS=6) 
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Figure 24. Average anterior infralimbic cortical Arc immunoreactivity. (n per group: PF=2; 
CET=2; CET-TH=2; CET-PTD=3; PTD-EAS=3; PTD-MAS=5) 
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Figure 25. Average posterior infralimbic Arc immunoreactivity. (n per group: PF=2; 
CET=2; CET-TH=2; CET-PTD=3; PTD-EAS=3; PTD-MAS=5) 
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Figure 26. Counts of active cells demonstrating that PFs had significantly more cellular 
activity than PTD-EAS subjects. (n per group: PF=5; CET=6; CET-TH=5; CET-PTD=5; 
PTD-EAS=7; PTD-MAS=6) 
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Figure 27. Active (Arc positive) cell counts demonstrating that PTD-EAS animals differed 
from PTD-MAS animals as they decreased and increased as compared to controls, 
respectively. (n per group: PF=5; CET=6; CET-TH=5; CET-PTD=6; PTD-EAS=8; PTD-
MAS=7) 
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Figure 28. Average anterior prelimbic Arc immunoreactivity. (n per group: PF=4; CET=5; 
CET-TH=4; CET-PTD=5; PTD-EAS=6; PTD-MAS=5) 
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Figure 29. Average posterior prelimbic Arc immunoreactivity. (n per group: PF=4; 
CET=5; CET-TH=4; CET-PTD=5; PTD-EAS=6; PTD-MAS=5) 
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Figure 30. Active cell counts demonstrating that PF subjects had significantly more 
activity than PTD-MAS animals. (n per group: PF=5; CET=5; CET-TH=5; CET-PTD=5; 
PTD-EAS=8; PTD-MAS=6) 
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